Sky Bear Technical Standards - Home
Search
×
FR

Placeholder headline

This is just a placeholder headline

ISO 7554-3:2026 Surgical instruments — Terms, measuring methods and test methods — Part 3: Test methods

$

192

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO 41002:2026 Facility management — Development of the facility management organization

$

305

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO 39004:2026 Road traffic safety — Good practice for service providers using digital platform

$

259

BUY NOW

ISO 23033:2021

ISO 23033:2021 Biotechnology – Analytical methods – General requirements and considerations for the testing and characterization of cellular therapeutic products

CDN $305.00

Description

This document provides general requirements for the testing of cellular therapeutic products intended for human use.

This document also provides considerations for the characterization of cellular therapeutic products, including approaches to select and design analytical methods that are fit for purpose.

Such considerations can be used to establish critical quality attributes for a cellular therapeutic product.

This document is applicable to cellular starting materials (including those for tissue engineered products) and intermediates of cellular therapeutic products.

This document is not applicable to tissues used in transplantation.

Edition

1

Published Date

2021-08-27

Status

PUBLISHED

Pages

35

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document provides general requirements for the testing of cellular therapeutic products intended for human use.

This document also provides considerations for the characterization of cellular therapeutic products, including approaches to select and design analytical methods that are fit for purpose.

Such considerations can be used to establish critical quality attributes for a cellular therapeutic product.

This document is applicable to cellular starting materials (including those for tissue engineered products) and intermediates of cellular therapeutic products.

This document is not applicable to tissues used in transplantation.

Previous Editions

Can’t find what you are looking for?

Please contact us at: